Can a stronger pill keep skin infection patients out of the hospital?
NCT ID NCT05852262
Summary
This study is testing whether a higher dose of the common oral antibiotic cephalexin is better than the standard dose for treating cellulitis, a common and painful skin infection. It involves 446 adults who visit the emergency department and are sent home with pills. The main goal is to see if the higher dose reduces treatment failure, preventing the need for stronger IV antibiotics or a return hospital visit.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELLULITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Enfant-Jésus Hospital
Québec, Quebec, Canada
-
Health Sciences North
Greater Sudbury, Ontario, P3E 2H2, Canada
-
Hôpital du Sacré-Cœur de Montréal
Montreal, Quebec, Canada
-
Kingston Health Sciences Centre
Kingston, Ontario, Canada
-
London Health Sciences Centre
London, Ontario, Canada
-
Queen Elisabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
-
Sinai Health System
Toronto, Ontario, Canada
-
South Health Campus
Calgary, Alberta, Canada
-
The Ottawa Hospital
Ottawa, Ontario, K1Y 4E9, Canada
-
Thunder Bay Health Sciences Centre
Thunder Bay, Ontario, Canada
Conditions
Explore the condition pages connected to this study.